John D. Ratliff

2018 - Laboratory Corp. of America Holdings

In 2018, John D. Ratliff earned a total compensation of $7.5M as Executive Vice President, Chief Executive Officer of Covance Drug Development at Laboratory Corp. of America Holdings, a 50% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$762,593
Option Awards$758,689
Salary$679,750
Stock Awards$5,103,644
Other$184,961
Total$7,489,637

Ratliff received $5.1M in stock awards, accounting for 68% of the total pay in 2018.

Ratliff also received $762.6K in non-equity incentive plan, $758.7K in option awards, $679.8K in salary and $185K in other compensation.

Rankings

In 2018, John D. Ratliff's compensation ranked 1,114th out of 14,244 executives tracked by ExecPay. In other words, Ratliff earned more than 92.2% of executives.

ClassificationRankingPercentile
All
1,114
out of 14,244
92nd
Division
Services
249
out of 2,378
90th
Major group
Health Services
16
out of 221
93rd
Industry group
Medical And Dental Laboratories
3
out of 76
96th
Industry
Medical Laboratories
3
out of 76
96th

Pay ratio

John D. Ratliff's Pay$7,489,637
Median Employee's Pay$43,230
Pay Ratio

173

to 1

In 2018, the annual total compensation of John D. Ratliff was $7,489,637.

The annual total compensation of the median employee at Laboratory Corp. of America Holdings was $43,230.

The ratio of John D. Ratliff's pay to the pay of median employee was therefore 173 to one.

Source: SEC filing on March 29, 2019.

Ratliff's colleagues

We found four more compensation records of executives who worked with John D. Ratliff at Laboratory Corp. of America Holdings in 2018.

2018

DAVID KING

Laboratory Corp. of America Holdings

Chief Executive Officer

2018

Gary Huff

Laboratory Corp. of America Holdings

Chief Executive Officer

2018

GLENN EISENBERG

Laboratory Corp. of America Holdings

Chief Financial Officer

2018

F EBERTS

Laboratory Corp. of America Holdings

Chief Legal Officer

News

You may also like